Standard Biotools (LAB) Other Non Operating Income (2010 - 2026)
Standard Biotools (LAB) reported Other Non Operating Income of -$5.6 million for Q1 2026, down 1092.95% year-over-year from $567000.0 in Q1 2025, and down 213.44% on a QoQ basis from $5.0 million in Q2 2025.
Standard Biotools (LAB) has 17 years of Other Non Operating Income data on file, last reported at -$5.6 million in Q1 2026.
- Quarterly Other Non Operating Income fell 1092.95% year-over-year to -$5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$667000.0 (up 69.78% YoY) and the FY2024 annual result came in at -$5.0 million, changed N/A from the prior year.
- Other Non Operating Income eased to -$5.6 million in Q1 2026 per LAB's latest filing, from $5.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $25.2 million in Q1 2024 and bottomed at -$5.6 million in Q1 2026.
- The 5-year median for Other Non Operating Income is $265000.0 (2022), against an average of $1.9 million.
- The widest annual swing landed in 2024, when Other Non Operating Income soared 2131.24%; it then slumped 1092.95% in 2026.
- Tracing LAB's Other Non Operating Income over 5 years: stood at -$699000.0 in 2022, then soared by 261.66% to $1.1 million in 2023, then plunged by 466.64% to -$4.1 million in 2024, then surged by 219.79% to $5.0 million in 2025, then slumped by 213.44% to -$5.6 million in 2026.
- Per Business Quant, the three latest LAB Other Non Operating Income figures stand at -$5.6 million (Q1 2026), $5.0 million (Q2 2025), and $567000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.63 Mn |
| Jun 30, 2025 | 4.96 Mn |
| Mar 31, 2025 | 567,000.00 |
| Dec 31, 2024 | -4.14 Mn |
| Sep 30, 2024 | 957,000.00 |
| Jun 30, 2024 | 412,000.00 |
| Mar 31, 2024 | 25.21 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | -699,000.00 |
| Sep 30, 2022 | -63,000.00 |
| Jun 30, 2022 | -174,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Sep 30, 2021 | 315,000.00 |
| Jun 30, 2021 | 504,000.00 |
| Mar 31, 2021 | -285,000.00 |
| Dec 31, 2020 | 248,000.00 |
| Sep 30, 2020 | 107,000.00 |
| Jun 30, 2020 | 463,000.00 |
| Mar 31, 2020 | -818,000.00 |
| Dec 31, 2019 | -3.00 Mn |
| Sep 30, 2019 | 205,000.00 |
| Mar 31, 2019 | -9.00 Mn |
| Dec 31, 2018 | 637,000.00 |
| Sep 30, 2018 | 117,000.00 |
| Mar 31, 2018 | 100,000.00 |
| Dec 31, 2017 | -186,000.00 |
| Sep 30, 2017 | 379,000.00 |
| Jun 30, 2017 | 183,000.00 |
| Mar 31, 2017 | 9,000.00 |
| Dec 31, 2016 | -640,000.00 |
| Sep 30, 2016 | -161,000.00 |
| Jun 30, 2016 | -44,000.00 |
| Mar 31, 2016 | -324,000.00 |
| Dec 31, 2015 | -268,000.00 |
| Sep 30, 2015 | -377,000.00 |
| Jun 30, 2015 | 608,000.00 |
| Mar 31, 2015 | -1.12 Mn |
| Dec 31, 2014 | -549,000.00 |
| Sep 30, 2014 | -338,000.00 |
| Jun 30, 2014 | -18,000.00 |
| Mar 31, 2014 | 48,000.00 |
| Dec 31, 2013 | 44,000.00 |
| Sep 30, 2013 | 709,000.00 |
| Jun 30, 2013 | -39,000.00 |
| Mar 31, 2013 | -213,000.00 |
| Dec 31, 2012 | -62,000.00 |
| Sep 30, 2012 | -75,000.00 |
| Jun 30, 2012 | 9,000.00 |
| Mar 31, 2012 | -61,000.00 |
| Dec 31, 2011 | -52,000.00 |
| Sep 30, 2011 | 25,000.00 |
| Jun 30, 2011 | 42,000.00 |
| Mar 31, 2011 | 66,000.00 |
| Dec 31, 2010 | 128,000.00 |
| Sep 30, 2010 | 246,000.00 |
| Jun 30, 2010 | 108,000.00 |